(Q34808921)

4 August 2017

1 reference

title

Is lead exposure the principal cause of essential hypertension? (English)

1 reference

4 August 2017

1 reference

Gonick HC

1

1 reference

4 August 2017

Behari JR

series ordinal

2

1 reference

4 August 2017

publication date

1 September 2002

1 reference

4 August 2017

1 reference

4 August 2017

volume

59

1 reference

4 August 2017

issue

3

1 reference

4 August 2017

page(s)

239-246

1 reference

The relationship between blood lead levels and blood pressure and its cardiovascular risk implications

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900207-4

7 January 2021

Blood pressure and other cardiovascular risk factors of long-term exposure to lead

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900207-4

7 January 2021

Body burdens of lead in hypertensive nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900207-4

7 January 2021

Non-occupational lead exposure and hypertension in northern Italy

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900207-4

7 January 2021

Association of blood lead to blood pressure in men aged 55 to 75 years: effect of selected social and biochemical confounders. NFR Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900207-4

7 January 2021

Occult lead intoxication as a cause of hypertension and renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900207-4

7 January 2021

Is a positive association between lead exposure and blood pressure supported by animal experiments?

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900207-4

7 January 2021

Lead exposure and conventional and ambulatory blood pressure: a prospective population study. PheeCad Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900207-4

7 January 2021

Lead and hypertension in a sample of middle-aged women

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900207-4

7 January 2021

Occupational lead exposure and blood pressure

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900207-4

7 January 2021

Effects of lead on vascular reactivity

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900207-4

7 January 2021

Lead-induced hypertension: interplay of nitric oxide and reactive oxygen species

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900207-4

7 January 2021

Chronic low-level lead exposure. Its role in the pathogenesis of hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900207-4

7 January 2021

Lead-induced hypertension: possible role of endothelial factors

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900207-4

7 January 2021

Effect of chelation treatment with dimercaptosuccinic acid (DMSA) on lead-related blood pressure changes

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900207-4

7 January 2021

Exposure of the U.S. population to lead, 1991-1994

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900207-4

7 January 2021

Relationship between "chelatable lead" and the indicator of exposure and effect in current and past occupational exposure

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900207-4

7 January 2021

Chelated lead in relation to lead in bone and ALAD genotype

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900207-4

7 January 2021

Contribution of lead to hypertension with renal impairment

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900207-4

7 January 2021

Effect of repeated occupational exposure to lead, cessation of exposure, and chelation on levels of lead in bone

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900207-4

7 January 2021

Kinetic analysis of lead metabolism in healthy humans

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900207-4

7 January 2021

Kinetics of lead in bone and blood after end of occupational exposure

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900207-4

7 January 2021

Determinants of bone and blood lead levels among community-exposed middle-aged to elderly men. The normative aging study

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900207-4

7 January 2021

CHRONIC LEAD NEPHROPATHY: THE DIAGNOSTIC USE OF CALCIUM EDTA AND THE ASSOCIATION WITH GOUT

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900207-4

7 January 2021

The Clinical Differentiation of Lead Gout from Primary Gout

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900207-4

7 January 2021

Blood pressure in four remote populations in the INTERSALT Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900207-4

7 January 2021

Aging, acculturation, salt intake, and hypertension in the Kuna of Panama

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900207-4

7 January 2021

Migration, blood pressure pattern, and hypertension: the Yi Migrant Study

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900207-4

7 January 2021

Lifestyle and hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900207-4

7 January 2021

Heavy metal levels in acculturated and unacculturated populations

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900207-4

7 January 2021

Blood lead concentrations in a remote Himalayan population

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900207-4

7 January 2021

Dietary salt reduction in hypertension--what is the evidence and why is it still controversial?

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900207-4

7 January 2021

Influence of parental history of hypertension on blood pressure

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900207-4

7 January 2021

Hypertension, hyperlipidemia and microalbuminuria

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900207-4

7 January 2021

Relationship between insulin resistance and nonmodulating hypertension: linkage of metabolic abnormalities and cardiovascular risk.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900207-4

7 January 2021

Kidney, salt intake, and Na+,K(+)-ATPase inhibitors in hypertension. 1990 Corcoran Lecture

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900207-4

7 January 2021

Sodium ions, calcium ions, blood pressure regulation, and hypertension: a reassessment and a hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900207-4

7 January 2021

Predominance of high molecular weight plasma Na(+)-K(+)-ATPase inhibitor in essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900207-4

7 January 2021

In vitro inhibition of Na-K-ATPase by trace metals: relation to renal and cardiovascular damage

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900207-4

7 January 2021

Effects of lead and a low-molecular-weight endogenous plasma inhibitor on the kinetics of sodium-potassium-activated adenosine triphosphatase and potassium-activated p-nitrophenylphosphatase

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900207-4

7 January 2021

Experimental investigations on the contraction induced by lead in arterial smooth muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900207-4

7 January 2021

Lead increases red cell sodium-lithium countertransport

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900207-4

7 January 2021

Increased sodium-lithium countertransport in red cells of patients with essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900207-4

7 January 2021

The intravenous furosemide test: a simple way to evaluate renin responsiveness

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900207-4

7 January 2021

Neurohumoral blood pressure regulation in lead exposure

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900207-4

7 January 2021

Chronic effects of lead on the renin-angiotensin system

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900207-4

7 January 2021

Reduced vascular beta-adrenergic receptors and catecholamine response in rats with lead induced hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900207-4

7 January 2021

Hyperkalemia and acidosis in lead nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900207-4

7 January 2021

Both brain angiotensin II and "ouabain" contribute to sympathoexcitation and hypertension in Dahl S rats on high salt intake.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900207-4

7 January 2021

Reduced sympathetic inhibition in salt-sensitive Japanese young adults.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900207-4

7 January 2021

Adrenomedullary secretion of epinephrine is increased in mild essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900207-4

7 January 2021

Effect of antihypertensive treatment on the increased beta 2-adrenoceptor density in patients with essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900207-4

7 January 2021

Relationships between kallikrein secretion, kallikrein excretion and beta-adrenoceptors in kidney cortical slices from neurogenic hypertensive dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900207-4

7 January 2021

Plasma levels of 6-keto-prostaglandin F1 alpha in normotensive subjects and patients with essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900207-4

7 January 2021

Altered levels of urinary prostanoids in lead-exposed workers

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900207-4

7 January 2021

Endothelial dysfunction and hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900207-4

7 January 2021

Hypercholesterolemia increases endothelial superoxide anion production

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900207-4

7 January 2021

Superoxide production in vascular smooth muscle contributes to oxidative stress and impaired relaxation in atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900207-4

7 January 2021

Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900207-4

7 January 2021

Pathological implications of nitric oxide, superoxide and peroxynitrite formation

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900207-4

7 January 2021

Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900207-4

7 January 2021

Acute hypertension impairs endothelium-dependent vasodilation

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900207-4

7 January 2021

Reduced plasma concentrations of nitrogen oxide in individuals with essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900207-4

7 January 2021

Plasma endothelin in human essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900207-4

7 January 2021

Endothelin and endothelin antagonists in hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900207-4

7 January 2021

Enhanced expression of endothelin-1 gene in resistance arteries in severe human essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900207-4

7 January 2021

Lead-induced hypertension. II. Response to sequential infusions of L-arginine, superoxide dismutase, and nitroprusside

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900207-4

7 January 2021

Altered nitric oxide metabolism and increased oxygen free radical activity in lead-induced hypertension: effect of lazaroid therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900207-4

7 January 2021

Lead-induced hypertension. III. Increased hydroxyl radical production

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900207-4

7 January 2021

Lead promotes hydroxyl radical generation and lipid peroxidation in cultured aortic endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900207-4

7 January 2021

Malondialdehyde, lipofuscin and activity of antioxidant enzymes during physical exercise in patients with essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900207-4

7 January 2021

Plasma hydrogen peroxide production in hypertensives and normotensive subjects at genetic risk of hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900207-4

7 January 2021

Are free radicals involved in the pathobiology of human essential hypertension?

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900207-4

7 January 2021

Role of increased oxygen free radical activity in the pathogenesis of uremic hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900207-4

7 January 2021

Imbalance of oxidants and antioxidants in haemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900207-4

7 January 2021

Diabetes mellitus, hypertension, and cardiovascular disease: which role for oxidative stress?

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900207-4

7 January 2021

A mechanism of oxygen free radical production in the Dahl hypertensive rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900207-4

7 January 2021

Increased oxidative stress in renal proximal tubules of the spontaneously hypertensive rat: a mechanism for defective dopamine D1A receptor/G-protein coupling

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900207-4

7 January 2021

Prevalence and determinants of hypertension in the urban population of Jaipur in western India.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900207-4

7 January 2021

10.1016/S0306-9877(02)00207-4

Identifiers

DOI

1 reference

4 August 2017

1 reference